Medicare Enrolled

Dr. Kiran Nair, D.O.

Pulmonary Disease · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
902 FROSTWOOD DR, Houston, TX 77024
7134678888
In practice since 2008 (17 years)
NPI: 1215199435 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nair from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nair? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nair

Dr. Kiran Nair is a pulmonary disease in Houston, TX, with 17 years in practice. Based on federal Medicare data, Dr. Nair performed 1,822 Medicare services across 990 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nair received a total of $45,292 from 73 pharmaceutical and/or device companies across 1242 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nair is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 22% volume in TX$ $45,292 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,822
Medicare services
Top 22% in TX for pulmonary disease
990
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~107 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, moderate complexity604$64$140
Office visit, established patient (30-39 min)339$96$175
Hospital follow-up visit, high complexity250$97$179
Office visit, established patient (20-29 min)191$67$125
Test to measure expiratory airflow and volume124$21$120
Initial hospital admission, moderate complexity114$106$240
New patient office visit (45-59 min)78$132$275
Initial hospital admission, high complexity53$138$325
Test to examine how well the lungs exchange gases19$45$75
Test to determine lung volumes using sensors17$41$85
New patient office visit (30-44 min)17$86$240
Office visit, established patient, complex (40-54 min)16$145$200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$45,292
Total received (2018-2024)
Avg $6,470/year across 7 years
Top 7% in TX for pulmonary disease
73
Companies
1,242
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,987 (55.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$11,485 (25.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,820 (19.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,454
2023
$9,889
2022
$19,848
2021
$3,178
2020
$2,407
2019
$3,081
2018
$2,435

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Mylan Specialty L.P.
$11,374
Intuitive Surgical, Inc.
$9,171
GlaxoSmithKline, LLC.
$3,712
AstraZeneca Pharmaceuticals LP
$3,261
Actelion Pharmaceuticals US, Inc.
$2,219
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,626
Pulmonx Corporation
$1,517
Regeneron Healthcare Solutions, Inc.
$978
Mallinckrodt Hospital Products Inc.
$978
GENZYME CORPORATION
$968
JAZZ PHARMACEUTICALS INC.
$864
Philips Electronics North America Corporation
$688
Electromed, Inc.
$580
Grifols USA, LLC
$515
United Therapeutics Corporation
$505
Harmony Biosciences LLC
$448
Genentech USA, Inc.
$442
Takeda Pharmaceuticals U.S.A., Inc.
$428
Insmed, Inc.
$425
Janssen Pharmaceuticals, Inc
$390
Amgen Inc.
$268
Axsome Therapeutics, Inc.
$222
Bayer HealthCare Pharmaceuticals Inc.
$200
Gilead Sciences, Inc.
$199
ZOLL Respicardia, Inc.
$194
Philips North America LLC
$193
HARMONY BIOSCIENCES LLC
$176
Sunovion Pharmaceuticals Inc.
$168
ANI Pharmaceuticals, Inc.
$155
ABBVIE INC.
$149
Ceribell, Inc.
$146
Merck Sharp & Dohme LLC
$146
Shire North American Group Inc
$143
INTUITIVE SURGICAL, INC.
$142
Abbott Laboratories
$127
E.R. Squibb & Sons, L.L.C.
$109
Advanced Respiratory, Inc
$100
Paratek Pharmaceuticals, Inc.
$98
Novartis Pharmaceuticals Corporation
$92
Mallinckrodt Enterprises LLC
$76
Eisai Inc.
$69
Inogen, Inc.
$66
Mallinckrodt LLC
$66
Circassia Pharmaceuticals Inc
$65
Merck Sharp & Dohme Corporation
$62
Avadel CNS Pharmaceuticals, LLC
$57
IDORSIA PHARMACEUTICALS US INC
$51
OptiNose US, Inc.
$46
Jazz Pharmaceuticals Inc.
$44
Phadia US Inc.
$37
ARBOR PHARMACEUTICALS, INC.
$34
Allergan Inc.
$32
Teva Pharmaceuticals USA, Inc.
$29
Exact Sciences Corporation
$29
Tactile Systems Technology Inc
$29
3B Medical, Inc.
$28
INOGEN, INC.
$28
PFIZER INC.
$27
SANOFI US SERVICES INC.
$25
SANOFI-AVENTIS U.S. LLC
$25
Exeltis, USA Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$22
Biogen, Inc.
$22
EISAI INC.
$22
Vapotherm Inc
$22
Sandoz Inc.
$21
MAYNE PHARMA INC.
$20
SANOFI PASTEUR INC.
$19
Inspire Medical Systems, Inc.
$19
Resmed Corp
$17
Harmony Biosciences Llc
$17
ADVANCED RESPIRATORY, INC
$14
Veran Medical Technologies, Inc.
$9
Top 3 companies account for 53.6% of total payments
Associated products mentioned in payments ›
(7999) SRC Und · (8685) OEM Other · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · Astral · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CHARTIS CATHETER · Ceribell Rapid Response EEG · Cologuard Collection Kit · DALVANCE · DORYX · DUAKLIR PRESSAIR · DUPIXENT · Da Vinci Surgical System · Dayvigo · Dymista · ELIQUIS · Esbriet · FARXIGA · FASENRA · FLUZONE QUADRIVALENT · Flexitouch Plus · GLASSIA · Horizant · INOGEN ONE G3 OXYGEN CONCENTRATOR · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · ION · ImmunoCAP · InogenOne · LONHALA MAGNAIR · LUMRYZ · LUNA · Mitra Clip system · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · POCKET EEG DEVICE · PURIFIED CORTROPHIN GEL · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · REMODULIN · Respiratoriy Care Undiv · SEEBRI · SKYCLARYS · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · Sunosi · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TREPROSTINIL · TUDORZA PRESSAIR · TYVASO · The Monarch Airway Clearance System · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · WAKIX · WINREVAIR · Wakix · Wellcentive Undiv · XARELTO · XOLAIR · XYREM · XYWAV · Xhance · Xolair · Xyrem · YUPELRI · Yupelri · ZEPHYR ENDOBRONCHIAL VALVE · ZERBAXA · inCourage · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (55%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for pulmonary disease in TX.

Equivalent to $2,486 per 100 Medicare services performed
Looking for a pulmonary disease in Houston?
Compare pulmonary diseases in the Houston area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
126
Per 100K population
2.6
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN MEMORIAL CITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Nair is a clinical cardiology specialist, with above-average Medicare volume (top 22% in TX), and high industry engagement (low-engagement, top 7%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Nair experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Nair performed 604 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nair receive payments from pharmaceutical companies?
Yes. Dr. Nair received a total of $45,292 from 73 companies across 1,242 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nair's costs compare to other pulmonary diseases in Houston?
Dr. Nair's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nair) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →